Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M
ORLANDO, FL / ACCESSWIRE / April 29, 2022 / Nutriband Inc. (NASDAQ:NTRB), a developer of transdermal pharmaceutical products, today announced...
News
Dr. Gregg Sturrus’ TEDx Talk(R) Features Halberd’s Extracorporeal Treatment of Neurodegenerative Diseases
JACKSON CENTER, PA / ACCESSWIRE / April 29, 2022 / A key member of Halberd Corporation's (OTC PINK:HALB) Research Team,...
Abeona Therapeutics Announces Presentation at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
NEW YORK and CLEVELAND, April 29, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell...
HEXO Announces Leadership Transition; Company Appoints Charlie Bowman as Chief Executive Officer and Julius Ivancsits as Chief Financial Officer
Scott Cooper Steps Down; Board of Directors Acknowledge Cooper in Stabilizing the Company Bowman and Ivancsits to Lead HEXO’s Continued...
Galecto Reports First Quarter Operating and Financial Results
BOSTON, April 29, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development...
Coherus BioSciences to Report First Quarter 2022 Financial Results on May 5th, 2022
REDWOOD CITY, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its first quarter...
Enlivex Announces Full Year 2021 Financial Results, Completion of Development of Frozen Formulation Allocetra™ Ahead of Schedule, and Provides Strategic & Business Updates
Development of frozen formulation Allocetra™, a primary cornerstone of Enlivex’s R&D efforts during the last two years, was successfully completed...
ReWalk Joins Israeli Technology Innovation Consortium for Human-Robot Interaction
The MAGNET Consortium program led by Israel’s Innovation Authority fosters collaboration through R&D grantsMARLBOROUGH, Mass., April 29, 2022 (GLOBE NEWSWIRE)...
Nass Valley Gardens Inc. Announces It Will Diversify Its Product Offering Which Will Include a Cosmetic Line and Hemp-Based Foods
WEST PALM BEACH, FL, April 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nass Valley Gardens Inc., a Nevada registered C-Corp and...
U.S. Food and Drug Administration Approves Camzyos (mavacamten) for the Treatment of Adults with Symptomatic New York Heart Association Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) to Improve Functional Capacity and Symptoms
LianBio to Continue Development of Camzyos in China and Other Asian TerritoriesSHANGHAI and PRINCETON, N.J., April 29, 2022 (GLOBE NEWSWIRE)...
Palisade Bio to Participate in the Virtual Investor Management and KOL Roundtable Event
Live moderated video webcast discussion among members of Management and a renowned Key Opinion Leader on Tuesday, May 3rd at...
Amedisys to Present at Multiple Healthcare Conferences in May
BATON ROUGE, La., April 29, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice,...
Athenex to Provide Corporate and Financial Update for the First Quarter 2022 on May 10, 2022
BUFFALO, N.Y., April 29, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development,...
ORYZON to Give Updates on Corporate Progress in May
Swiss Biotech DayLSX World Congress BioEquity Europe H.C. Wainwright Global Investment ConferencePrecisionMed Expo & Summit Foro MedCap BMEMADRID, Spain and...
BioRestorative Therapies Hosts Principal Investigator Meeting for its BRTX-100® Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
MELVILLE, N.Y., April 29, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage...
Lexicon Pharmaceuticals to Host First Quarter 2022 Financial Results Conference Call and Webcast on May 5, 2022
THE WOODLANDS, Texas, April 29, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its first quarter 2022...
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
MENLO PARK, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) an eyecare technology company focused on...
Zymergen to Participate in the BofA Securities 2022 Healthcare Conference
EMERYVILLE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced the company will be...
Covetrus Announces First Quarter 2022 Earnings Release Date and Conference Call Information
PORTLAND, Maine--(BUSINESS WIRE)--Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release first...
iZafe Group Q1 Interim Report, January-March 2022
STOCKHOLM, SE / ACCESSWIRE / April 29, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group AB (publ.) - today April 29, releases...